imiquimod has been researched along with Carcinoma, Epidermoid in 164 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 75 (45.73) | 29.6817 |
2010's | 64 (39.02) | 24.3611 |
2020's | 25 (15.24) | 2.80 |
Authors | Studies |
---|---|
Jonnalagadda, S; Palle, K; Reedy, M | 1 |
Ahmed, I; Bowden, SJ; Gaunt, C; Gaunt, P; Green, AC; Harwood, CA; Hasan, ZU; Hogan, S; Homer, V; Ismail, F; Jefferson-Hulme, Y; Kentley, J; Lear, JT; Matin, RN; Milligan, A; Mitchell-Worsford, L; Proby, CM; Thomson, J; Van-de-Velde, V; Wheatley, K; Whitmarsh, T | 1 |
Ahmady, S; Arits, AHMM; de Rooij, MJM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF | 1 |
Cheng, B; Etzkorn, JR; Giordano, CN; Higgins, HW; Miller, CJ; Shin, TM; Sobanko, JF; Veerabagu, S | 1 |
Borroni, RG; Bressan, A; Cortese, A; Costanzo, A; Fiorillo, G; Toso, F; Tronconi, MC | 1 |
Algarin, YA; Jambusaria-Pahlajani, A; Patel, VA; Ruiz, E | 1 |
Arthur, A; Badiavas, E; Kirsner, R; Nahm, W; Nichols, A; Rapoport, E; Shen, J; Wyant, W | 1 |
Cornacchia, L; Lai, M; Longo, C; Pampena, R; Pellacani, G; Peris, K | 1 |
Dirschka, T; Gollnick, H; Kerl, H; Kunstfeld, R; Ostendorf, R | 1 |
Collins, A; Doerfler, L; Savas, J | 1 |
Arimura, A; Kanekura, T; Kirishima, M; Tanimoto, A | 1 |
Marchetti, MA; Marghoob, AA; Navarrete-Dechent, C | 1 |
Linares-Gonzalez, L; Navarro-Triviño, FJ; Ródenas-Herranz, T; Ruiz-Villaverde, R | 1 |
Conforti, C; Corneli, P; di Meo, N; Dianzani, C; Farinazzo, E; Giuffrida, R; Magaton Rizzi, G; Moret, A; Zalaudek, I | 1 |
Corbeddu, M; Ferreli, C; Fumo, G; Robustelli Test, E; Rongioletti, F | 1 |
Fayne, R; Nanda, S; Nichols, A; Shen, J | 1 |
Brogden, DRL; Kontovounisios, C; Mills, SC; Pellino, G; Tekkis, P; Walsh, U | 1 |
Aydin, AM; Chahoud, J; Cheryian, SK; Hajiran, A; Pow-Sang, JM; Spiess, PE; Zemp, L | 1 |
Benedetto, C; Bertero, L; Bevilacqua, F; Borella, F; Carosso, AR; Cassoni, P; Castellano, I; Collemi, G; Cosma, S; Gallio, N; Micheletti, L; Preti, M | 1 |
Feldman, SR; Heron, CE | 1 |
Badiavas, EV; Gonzalez, AM; Kirsner, RS; Moore, K; Nagrani, N; Nahm, WJ; Nichols, AJ; Shen, J; Zito, PM | 1 |
Fontenete, S; Haedersdal, M; Lerche, CM; Olesen, UH; Paasch, U; Perez-Moreno, M | 1 |
Kerner, JD; Kerner, JV; Ondo, AL; Ondo, IP; Shanler, SD; Trainor, P | 1 |
Giacomantonio, CA; Helyer, LK; Pasternak, S; Peltekian, K; Simms, GA; Stein, J; Vidovic, D; Walsh, M | 1 |
Bennardo, L; Cisale, GY; Nisticò, SP; Pentangelo, G; Provenzano, E | 1 |
Bennardo, F; Bennardo, L; Dastoli, S; Giudice, A; Morrone, P; Nisticò, SP; Passante, M; Patruno, C; Provenzano, E | 1 |
Brewer, JD; Lang, ME; Stewart, JR | 1 |
Arron, ST; Caputo, M; Charruyer, A; Fong, S; Foster, RD; Ghadially, R; Horton, KM; North, JP; Sano, S; Sklar, S; Soeung, C; Tabernik, L; Taneja, M; Uchida, Y; Vitcov, GG; Yue, L | 1 |
Shi, L; Wang, P; Wang, X; Zhang, G; Zhang, H; Zhang, L; Zhao, Z; Zhou, Z | 1 |
Chen, WR; Luo, M; Shi, L; Wang, B; Wang, P; Wang, X; Yang, D; Zhang, F; Zhang, G; Zhang, H; Zhang, L; Zhang, Y; Zhou, F | 1 |
Que, SKT; Schmults, CD; Zwald, FO | 1 |
Baraldi, C; Dika, E; Fanti, PA; Guglielmo, A; Lambertini, M; Patrizi, A; Ravaioli, GM; Scarfì, F; Veronesi, G | 1 |
Bhatta, AK; Ji, J; Keyal, U; Wang, P; Wang, X; Zhang, G; Zhao, Z; Zhu, L | 1 |
Guevara-Gutiérrez, E; Hernández-Torres, M; Ledesma, GS; Ruiz-González, JF; Tlacuilo-Parra, A | 1 |
Corbett, A; Kermode, AG; Reddel, SW; Triplett, J | 1 |
Asgari, MM; Chren, MM; Friedman, GD; Neugebauer, R; Sokil, M; Su, KA; Zhu, Z | 1 |
Gupta, P; Kakkar, N; Singh, H; Singh, M; Zadeng, Z | 1 |
Bianchi, L; Caposiena Caro, RD; Di Prete, M; Didona, D; Orlandi, A; Sechi, A | 1 |
Council, ML; Nemer, KM | 1 |
Chitwood, K; Cohen, G; Etzkorn, J | 1 |
Dosekun, O; Farrugia, P; Lewis, F; Sethi, G | 1 |
Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N | 2 |
Bierhoff, E; Dirschka, T; Schmitz, L | 1 |
Bejarano, PA; Berho, M; Boutros, M | 1 |
Dhote, V; Gupta, V; Paul, BN; Trivedi, P | 1 |
Chang, IK; Choi, DK; Hur, GM; Im, M; Kim, CD; Lee, JH; Lee, Y; Li, ZJ; Lim, JW; Seo, YJ; Sohn, KC; Zhang, T | 1 |
Bontumasi, NM; Hurst, EA; Sheinbein, D | 1 |
Philipp-Dormston, WG | 1 |
Chen, YJ; Chen, YY; Huang, SW; Kao, JK; Liang, SM; Shieh, JJ; Wang, ST; Wu, CY | 1 |
Egekvist, H; Erlendsson, AM; Haedersdal, M; Lorentzen, HF; Philipsen, PA; Stausbøl-Grøn, B; Stender, IM | 1 |
Baraldi, C; Dika, E; Fanti, PA; Patrizi, A; Venturi, M | 1 |
Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K | 1 |
Mohd Amin, MC; Rehman, K; Yuen, NP; Zulfakar, MH | 1 |
Caglia, M; Hashemi, P; Kim, C; Shulman, K | 1 |
Bartha, Á; Dirschka, T; Schmitz, L | 1 |
Araki, Y; Arima, M; Iwata, Y; Kobayashi, T; Matsunaga, K; Numata, S; Okamura, K; Sugiura, K; Suzuki, T; Yagami, A | 1 |
Aneiros-Fernandez, J; Blasco-Morente, G; Martinez-Lopez, A; Naranjo-Diaz, MJ; Perez-Lopez, I; Ruiz-Villaverde, R; Tercedor-Sanchez, J | 1 |
Camacho-Martinez, F; Fernández-Crehuet, P; Pérez-Gil, A; Rios-Martin, JJ; Ruiz-Villaverde, R | 1 |
Neuhaus, I; North, J; Valdebran, M | 1 |
Brodland, DG; Murphy, ME; Zitelli, JA | 1 |
Chimenti, S; Saraceno, R; Teoli, M | 1 |
Clark, RA; Edwards, V; Hijnen, D; Huang, SJ; Kim, JE; Kupper, TS; Lambert, J; Miller, DM; Mollet, IG; Murphy, GF; Muthukuru, M; Schanbacher, CF | 1 |
French, LE; Hofbauer, GF; Koch, S; Läuchli, S; Pini, AM; Schärer, L | 1 |
Arechavala, RS; García-Río, I; González, LC; González-Pérez, R; Michelena, IA; Murua, AA; Santarén, BC; Urra, IT | 1 |
Baer, KE; Bergman, PJ; Craft, D; Gill, VL; Leung, C | 1 |
Stockfleth, E | 1 |
Ulrich, C | 1 |
Calarese, AW; Clark, RA; Hijnen, D; Huang, SJ; Kupper, TS; Miller, DM; Mollet, IG; Murphy, GF; Schanbacher, CF; Schmults, CD | 1 |
Coldiron, BM; Rogers, HW | 1 |
Bernhard, JD; Bordeaux, JS; Love, WE | 1 |
Baek, GH; Cho, JH; Chung, MS; Gong, HS; Roh, YH | 1 |
Collins, C; Harrad, RA; Kennedy, CT; Ross, AH | 1 |
Cordoro, KM; Greer, KE; Lonergan, CL; McNamara, EK | 1 |
Muhn, C; Rosen, N; Shoimer, I | 1 |
Adam, F; Fenske, NA; Spencer, J | 1 |
Kerl, H; Kopera, D | 1 |
Chrisovergis, A; Eleftheriadou, A; Ferekidou, E; Gkoulioni, V; Kandiloros, D; Lazaris, ACh; Yiotakis, I | 1 |
Braga, JC; Busam, K; Dusza, SW; Gill, M; Halpern, AC; Marghoob, AA; Scope, A; Terushkin, V | 1 |
Barton, SE; Bower, M; Dixon, G; Fox, PA; Francis, N; Nathan, M; Singh, N; Weir, J | 1 |
Doherty, SD; Rosen, T; Shah, AY | 1 |
Aaronson, NK; Blok, LJ; Ewing, PC; Gundy, CM; Heijmans-Antonissen, C; Helmerhorst, TJ; Quint, WG; Terlou, A; van Beurden, M; van Seters, M | 1 |
Delaney, T; Foxton, G | 1 |
Frankel, A; Goldenberg, G | 1 |
Anolik, R; Brightman, L; Geronemus, R; Warycha, M | 1 |
Barysch, MJ; Dummer, R; Kamarashev, J; Lockwood, LL | 1 |
McLaughlin, PJ; Stucki, JK; Zagon, IS | 1 |
Chu, J; Hartman, R; Meehan, S; Patel, R; Stein, JA | 1 |
El Tal, AK; MacFarlane, DF | 1 |
Fotiadou, C; Giannopoulou, C; Ioannides, D; Lazaridou, E | 1 |
Jadotte, YT; Schwartz, RA | 1 |
Attili, SK; Fleming, C; Ibbotson, SH | 1 |
Digiovanni, J; Kamijima, R; Nakajima, K; Sano, S; Takaishi, M; Yokogawa, M | 1 |
Ahn, MY; Ahn, SG; Cheong, HH; Kwon, SM; Lee, J; Min, SK; Park, JH; Yoon, JH | 1 |
He, Q; Introcaso, CE; Kovarik, CL; Rady, PL; Tyring, SK | 1 |
Sullivan, TJ | 1 |
de C Monteiro, JS; de Oliveira, SC; de Souza, SC; dos Santos, JN; Gurgel, CA; Pinheiro, AL; Reis Júnior, JA | 1 |
Firnhaber, JM | 1 |
Cleaver, L; Knabel, P | 1 |
Guill, CK; Orengo, I; Rosen, T | 1 |
Hruza, G | 1 |
Barten, M; Gross, G; Gundlach, KK; Saka, B; Wenzel, K; Zimmermann, R | 1 |
Garland, SM | 1 |
Hamza, S; Skelton, H; Smith, KJ | 2 |
Campagne, G; Martínez, A; Roca, M | 1 |
Goldberg, LH; Peterson, SR | 1 |
Benninghoff, B; Bong, AB; Drewniok, C; Geilen, CC; Gollnick, H; Herz, J; Reifenberger, J; Schön, M; Schön, MP; Slade, HB | 1 |
Dorn, C; Kupka, M; Petrow, W; Richter, ON; Ulrich, U; Wardelmann, E | 1 |
Schmook, T; Stockfleth, E | 1 |
Beyeler, M; Burg, G; Dummer, R; Morcinek, J | 1 |
Del Rosso, JQ | 1 |
Chosidow, O; Dummer, R | 1 |
Danielsen, AG; Sand, C; Weismann, K | 1 |
Chen, K; Shumack, S | 1 |
Kossard, S | 1 |
Reifenberger, J; Schön, MP | 1 |
Alam, M; Goldberg, LH; Silapunt, S | 1 |
Oster-Schmidt, C | 1 |
Arlette, JP; Trotter, MJ | 1 |
Hengge, UR; Schaller, J | 2 |
Cruces, M; de la Torre, C; Feal, C; Flórez, A | 1 |
Ladd, DJ; Lin, R; Powell, DJ; Way, BV | 1 |
Huntley, A; Navi, D | 1 |
Dummer, R; Urosevic, M | 1 |
Armario-Hita, J; Fernández-Vozmediano, J | 1 |
Martín-García, RF | 1 |
Delli, F; Dionyssopoulos, A; Koussidou-Eremondi, T; Mandekou-Lefaki, I; Mourellou-Tsatsou, O | 1 |
Keller, CD | 1 |
Atkins, CL; Brown, VL; Cerio, R; Ghali, L; Harwood, CA; Proby, CM | 1 |
Higgins, SP; Poluri, RM | 1 |
Dirschka, T; Oster-Schmidt, C | 1 |
Altmeyer, P; Markus, S; Oster-Schmidt, C | 1 |
Haustein, UF; Paasch, U | 1 |
Ogawa, H; Palungwachira, P | 1 |
Derry, S; Hadley, G; Moore, RA | 1 |
Konstantopoulou, M; Lord, MG; Macfarlane, AW | 1 |
Berman, B; Bienstock, L; Kuritzky, L; Mayeaux, EJ; Tyring, SK | 1 |
Gibson, SJ; Inglefield, JR; Larson, CJ; Lebrec, H; Miller, RL | 1 |
Chimenti, S; Fargnoli, MC; Lozzi, GP; Micantonio, T; Peris, K | 1 |
Dissemond, J; Grabbe, S | 1 |
Adim, SB; Baskan, EB; Toker, S; Tunali, S; Turan, A | 1 |
Goh, MS | 1 |
Carrington, PR; D'Addario, S | 1 |
Mings, SM; Ondo, AL; Pestak, RM; Shanler, SD | 1 |
Berthelot, C; Dickerson, MC; He, Q; Niroomand, F; Pandya, AG; Rady, P; Tyring, SK | 1 |
Dixon, A | 1 |
Assimakopoulos, DA; Benton, J; Fika, Z; Karkos, PD | 1 |
Carroll, MT; Tillman, DK | 1 |
Bunker, CB; Singh, S | 1 |
Ferrándiz, C | 1 |
Amerio, P; Bichel, J; Euvrard, S; Guidi, B; Proby, CM; Rønnevig, J; Slade, HB; Stockfleth, E; Ulrich, C; van de Kerkhof, PC | 1 |
Krawtchenko, N; Mann, I; Roewert-Huber, J; Sterry, W; Stockfleth, E; Ulrich, M | 1 |
Bichel, J; Carey-Yard, M; Sterry, W; Stockfleth, E | 1 |
Miller, WH; Peters-Kennedy, J; Scott, DW | 1 |
Donahue, RN; McLaughlin, PJ; Rogosnitzky, M; Zagon, IS | 1 |
Warshauer, BL; Warshauer, E | 1 |
Cohen, GF; Taliaferro, SJ | 1 |
Pehoushek, J; Smith, KJ | 1 |
Hengge, UR; Stark, R | 1 |
Bieber, T; Gerdsen, R; Petrow, W; Richter, O; Uerlich, M | 1 |
Schroeder, TL; Sengelmann, RD | 1 |
40 review(s) available for imiquimod and Carcinoma, Epidermoid
Article | Year |
---|---|
Advances in Topical Treatments of Cutaneous Malignancies.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Quality of Life; Skin Neoplasms | 2023 |
Treatments of actinic cheilitis: A systematic review of the literature.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Dermabrasion; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Photochemotherapy; Precancerous Conditions; Treatment Outcome | 2020 |
Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials.
Topics: Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diclofenac; Facial Neoplasms; Female; Gels; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Scalp; Skin Cream | 2020 |
Nonsurgical Treatments for Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Programmed Cell Death 1 Receptor; Pyridines; Radiotherapy; Skin Neoplasms; Watchful Waiting | 2019 |
Successful treatment of micaceous balanitis with 5% topical imiquimod: case report and review of the literature.
Topics: Administration, Topical; Adult; Balanitis; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Male; Penile Neoplasms; Precancerous Conditions; Treatment Outcome | 2020 |
Current therapies for actinic keratosis.
Topics: Aftercare; Carcinoma, Squamous Cell; Chemexfoliation; Cryotherapy; Curettage; Dermoscopy; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Practice Guidelines as Topic; Protective Clothing; Skin; Skin Neoplasms; Sunlight; Sunscreening Agents | 2020 |
Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic review.
Topics: Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; HIV Infections; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections | 2021 |
Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Neuroendocrine Tumors; Paget Disease, Extramammary; Prognosis; Vulvar Neoplasms | 2020 |
Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Graft Rejection; Humans; Imiquimod; Immunocompromised Host; Immunosuppression Therapy; Infusions, Intralesional; Interleukin-2; Kidney Transplantation; Liver Transplantation; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Transplant Recipients; Treatment Outcome | 2021 |
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms | 2021 |
Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Skin Neoplasms | 2022 |
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Niacinamide; Photochemotherapy; Retinoids; Skin Neoplasms | 2019 |
Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferon alpha-2; Interferon-alpha; Keratoacanthoma; Methotrexate; Recombinant Proteins; Skin Neoplasms | 2013 |
Anal squamous intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Photochemotherapy; Watchful Waiting | 2013 |
Actinic keratoses.
Topics: Aged; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Dermatology; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Lasers; Medical Oncology; Models, Biological; Organ Transplantation; Photochemotherapy; Retinoids; Skin Neoplasms | 2009 |
Topical treatment of field cancerization.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Organ Transplantation; Photochemotherapy; Recurrence; Skin Neoplasms; Tissue Distribution | 2009 |
Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Metabolic Clearance Rate; Skin Neoplasms | 2009 |
Actinic keratoses: past, present and future.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cryosurgery; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Keratosis, Actinic; Photochemotherapy; Precancerous Conditions; Skin Neoplasms | 2010 |
Actinic cheilitis: a treatment review.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Caustics; Cheilitis; Cryosurgery; Electrocoagulation; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Trichloroacetic Acid | 2010 |
Do lasers or topicals really work for nonmelanoma skin cancers?
Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemexfoliation; Dermatologic Agents; Fluorouracil; Humans; Imiquimod; Laser Therapy; Nicotinic Acids; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms | 2011 |
Extramammary Paget disease.
Topics: Aminoquinolines; Antineoplastic Agents; Asian People; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnostic Errors; Eczema; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Skin Neoplasms | 2011 |
Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: a case series and review of the literature.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eye; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms | 2012 |
Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Fluorouracil; Humans; Imiquimod; Mitomycin; Orbital Neoplasms; Skin Neoplasms | 2012 |
Diagnosis and treatment of Basal cell and squamous cell carcinoma.
Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatologic Surgical Procedures; Desiccation; Fluorouracil; Humans; Imiquimod; Mohs Surgery; Risk Factors; Skin; Skin Neoplasms | 2012 |
Imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Molluscum Contagiosum; Skin Neoplasms | 2003 |
The imidazoquinolines and their place in the therapy of cutaneous disease.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms | 2003 |
Bowenoid papulosis of the vulva-immunotherapeutical approach with topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Diabetes Mellitus, Type 1; Female; Humans; Imiquimod; Immunotherapy; Papillomaviridae; Papillomavirus Infections; Vulvar Neoplasms | 2003 |
Current treatment patterns in non-melanoma skin cancer across Europe.
Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Dermatology; Europe; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms | 2003 |
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors | 2003 |
New and emerging topical approaches for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diclofenac; Humans; Imiquimod; Keratosis; Skin Neoplasms; Treatment Outcome; United States | 2003 |
Imiquimod: mode of action and therapeutic potential.
Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Imiquimod; Immune System; Papillomaviridae; Papillomavirus Infections; Skin Diseases; Skin Neoplasms | 2003 |
Topical and light-based treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclooxygenase Inhibitors; Diclofenac; Fluorouracil; Humans; Hyaluronic Acid; Imiquimod; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Precancerous Conditions; Retinoids; Skin Neoplasms; Vitamin A | 2003 |
Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment.
Topics: Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Female; Humans; Imiquimod; Male; Papillomavirus Infections; Skin; Skin Neoplasms; Ultraviolet Rays | 2004 |
Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms | 2004 |
Role of imiquimod in skin cancer treatment.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Imiquimod; Immunologic Factors; Melanoma; Skin Neoplasms | 2004 |
[Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Precancerous Conditions; Prospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Ultraviolet Rays | 2003 |
Imiquimod for actinic keratosis: systematic review and meta-analysis.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratosis; Ointments; Randomized Controlled Trials as Topic; Skin Neoplasms | 2006 |
Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Consensus Development Conferences as Topic; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Practice Guidelines as Topic; Risk Factors; Skin Neoplasms; Ultraviolet Rays | 2006 |
[Actinic keratosis].
Topics: Adjuvants, Immunologic; Age Factors; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Humans; Imiquimod; Interferon Inducers; Keratosis; Laser Therapy; Male; Ointments; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Time Factors; Ultraviolet Rays | 2006 |
Update on actinic keratosis in clinical trial experience with imiquimod.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratosis; Neoplasms, Radiation-Induced; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 2007 |
9 trial(s) available for imiquimod and Carcinoma, Epidermoid
Article | Year |
---|---|
Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Topics: Carcinoma, Squamous Cell; Feasibility Studies; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Organ Transplantation; Sunscreening Agents; Transplant Recipients; Treatment Outcome | 2022 |
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Skin Neoplasms; Treatment Outcome | 2022 |
A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Carcinoma, Squamous Cell; Double-Blind Method; HIV Infections; HIV-1; Homosexuality, Male; Humans; Imiquimod; Male | 2010 |
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Body Image; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Quality of Life; Sexuality; Vulvar Neoplasms | 2011 |
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Imiquimod; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Ointments; Precancerous Conditions; Risk Factors; Skin; Skin Neoplasms | 2005 |
Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome | 2006 |
Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.
Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imiquimod; Immunocompromised Host; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Organ Transplantation; Skin Neoplasms; Treatment Outcome | 2007 |
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryosurgery; Esthetics; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunocompetence; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 2007 |
Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Facial Neoplasms; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Patient Compliance; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 2007 |
115 other study(ies) available for imiquimod and Carcinoma, Epidermoid
Article | Year |
---|---|
Case Report: Intra-Tumoral Vaccinations of Quadrivalent HPV-L1 Peptide Vaccine With Topical TLR-7 Agonist Following Recurrence: Complete Resolution of HPV-HR-Associated Gynecologic Squamous Cell Carcinomas in Two Patients.
Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections; Salvage Therapy; Toll-Like Receptor 7 | 2021 |
A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2022 |
Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Eyelids; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome | 2022 |
Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.
Topics: Carcinoma, Squamous Cell; Chemoprevention; Fluorouracil; Humans; Imiquimod; Keratinocytes; Keratosis, Actinic; Prospective Studies; Treatment Outcome; Tretinoin | 2023 |
Eruptive squamous cell carcinoma in a patient treated with concomitant pembrolizumab and imiquimod.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Lung Neoplasms; Neoplasms, Second Primary; Skin Neoplasms; Urinary Bladder Neoplasms | 2019 |
Contemporary management of actinic keratosis.
Topics: Carcinoma, Squamous Cell; Cryotherapy; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms | 2021 |
Efficacy of Imiquimod 3.75% for the treatment of extensive Bowen's disease of the face in an elderly patient.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome | 2020 |
Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma
Topics: Administration, Cutaneous; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnosis, Differential; Ear, External; Fluorouracil; Humans; Imiquimod; Male; Mohs Surgery; Skin Neoplasms | 2020 |
Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity.
Topics: Administration, Topical; Adult; Aged; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cohort Studies; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Treatment Outcome | 2021 |
Ingenol Mebutate and the Treatment of Actinic Keratosis.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diterpenes; Fluorouracil; Humans; Imiquimod; Incidence; Keratosis, Actinic; Patient Preference; Photochemotherapy; Photosensitizing Agents; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2021 |
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cost-Benefit Analysis; Cryotherapy; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Tretinoin | 2021 |
Tumor Clearance and Immune Cell Recruitment in UV-Induced Murine Squamous Cell Carcinoma Exposed to Ablative Fractional Laser and Imiquimod Treatment.
Topics: Animals; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Imiquimod; Lasers; Mice; Skin Neoplasms; Ultraviolet Rays | 2021 |
Treatment of Cutaneous Squamous Cell Carcinoma In Situ With Curettage Followed by Topical Imiquimod 5% Cream.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Surveys and Questionnaires | 2021 |
Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Humans; Imiquimod; Lip; Neoplasm Recurrence, Local; Papillomavirus Infections | 2021 |
Brief Report: Interleukin-17A-Dependent Asymmetric Stem Cell Divisions Are Increased in Human Psoriasis: A Mechanism Underlying Benign Hyperproliferation.
Topics: Aminoquinolines; Animals; Asymmetric Cell Division; Carcinoma, Squamous Cell; Cell Proliferation; Homeostasis; Humans; Imiquimod; Interleukin-17; Mice; Psoriasis | 2017 |
Successful treatment of giant invasive cutaneous squamous cell carcinoma by plum-blossom needle assisted photodynamic therapy sequential with imiquimod: Case experience.
Topics: Aged, 80 and over; Aminoquinolines; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Needles; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2018 |
Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumour immunogenicity.
Topics: Adjuvants, Immunologic; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Combined Modality Therapy; Female; HMGB1 Protein; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Imiquimod; Immunotherapy; Laser Therapy; Mice; Middle Aged; Phototherapy; Skin Neoplasms | 2018 |
Reply to: "Cutaneous squamous cell carcinoma progression during imiquimod treatment".
Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Skin Neoplasms | 2018 |
Cutaneous squamous cell carcinoma progression during imiquimod treatment.
Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Skin Neoplasms | 2018 |
Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Topics: Aged; Aminolevulinic Acid; Animals; Apoptosis; Carcinoma, Squamous Cell; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Imiquimod; Inflammation Mediators; Male; Mice; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; T-Lymphocytes | 2018 |
[Riesgo de recurrencia y de nuevas neoplasias cutáneas malignas en sujetos mexicanos con carcinoma basocelular].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Electrocoagulation; Female; Humans; Imiquimod; Male; Margins of Excision; Middle Aged; Mohs Surgery; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Risk; Skin Neoplasms; Young Adult | 2018 |
Warts and all: Fingolimod and unusual HPV-associated lesions.
Topics: Ankle; Antineoplastic Agents; Anus Neoplasms; Carcinoma, Squamous Cell; Cryotherapy; Fingers; Fingolimod Hydrochloride; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunosuppressive Agents; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Papillomavirus Infections; Warts | 2019 |
Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
Topics: Administration, Cutaneous; Aged; California; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comparative Effectiveness Research; Female; Fluorouracil; Humans; Imiquimod; Intention to Treat Analysis; Keratinocytes; Keratosis, Actinic; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Risk Factors; Skin Neoplasms | 2019 |
Treatment of squamous cell carcinoma of the eyelid with imiquimod 5% cream.
Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Eyelid Neoplasms; Humans; Imiquimod; Magnetic Resonance Imaging; Male; Skin Cream | 2019 |
Treatment of recalcitrant squamous carcinoma in situ of penis with tapering imiquimod 5-3.75% cream.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Middle Aged; Ointments; Penile Neoplasms | 2019 |
Vulval disease in HIV-positive women attending a tertiary vulval dermatology clinic over a five-year period.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Imiquimod; Middle Aged; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Diseases | 2013 |
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.
Topics: Aminoquinolines; Carcinoma, Squamous Cell; Case Management; Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Diclofenac; Disease Management; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Radiation-Induced; Photochemotherapy; Practice Guidelines as Topic; Skin Neoplasms; Sunscreening Agents; United Kingdom; United States; Watchful Waiting | 2013 |
Optical coherence tomography imaging of erythroplasia of Queyrat and treatment with imiquimod 5% cream: a case report.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Erythroplasia; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Tomography, Optical Coherence | 2014 |
Development of novel topical drug delivery system containing cisplatin and imiquimod for dual therapy in cutaneous epithelial malignancy.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Drug Delivery Systems; Humans; Imiquimod; Mice; Microscopy, Fluorescence; Rats, Wistar; Skin Neoplasms | 2014 |
Imiquimod induces apoptosis of squamous cell carcinoma (SCC) cells via regulation of A20.
Topics: Aminoquinolines; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA-Binding Proteins; Humans; Imiquimod; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Nuclear Proteins; Toll-Like Receptor 7; Tumor Necrosis Factor alpha-Induced Protein 3 | 2014 |
Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Attitude of Health Personnel; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatology; Dermoscopy; Diclofenac; Disease Management; Guideline Adherence; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Photochemotherapy; Photosensitivity Disorders; Physicians; Practice Guidelines as Topic; Practice Patterns, Physicians'; Skin Neoplasms; Sunlight; Surveys and Questionnaires | 2014 |
Combination therapy for perianal squamous cell carcinoma in situ with imiquimod and photodynamic therapy.
Topics: Aminolevulinic Acid; Aminoquinolines; Anal Canal; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Dissection; Female; Humans; Imiquimod; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Postoperative Complications; Skin Neoplasms; Treatment Outcome | 2014 |
Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms | 2015 |
Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy.
Topics: Adenosine Triphosphate; Aminoquinolines; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Enzyme Activation; Gene Silencing; Humans; Imiquimod; Melanoma; Myeloid Cell Leukemia Sequence 1 Protein; Myeloid Differentiation Factor 88; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2015 |
Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cross-Sectional Studies; Cryotherapy; Denmark; Dermatology; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Outpatient Clinics, Hospital; Photochemotherapy; Photosensitizing Agents; Practice Patterns, Physicians'; Private Practice; Sex Factors; Skin Neoplasms | 2016 |
Non-melanoma skin cancer: to Mohs or not to Mohs?
Topics: Adult; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Follow-Up Studies; Humans; Imiquimod; Male; Microsurgery; Skin Neoplasms | 2015 |
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays | 2016 |
Immunomodulatory Effectiveness of Fish Oil and omega-3 Fatty Acids in Human Non-melanoma Skin Carcinoma Cells.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Drug Combinations; Fatty Acids, Omega-3; Fish Oils; Humans; Imiquimod; Immunosuppressive Agents; Interleukin-10; Interleukin-6; Skin Neoplasms; Tumor Necrosis Factor-alpha | 2016 |
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin | 2016 |
Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Male; Neoplasm Invasiveness; Scalp; Skin Neoplasms | 2016 |
Case of Japanese Hermansky-Pudlak syndrome patient with deeply invasive squamous cell carcinoma and multiple lesions of actinic keratosis on the face and neck.
Topics: Administration, Cutaneous; Adult; Carcinoma, Squamous Cell; Face; Hermanski-Pudlak Syndrome; Humans; Imiquimod; Japan; Keratosis, Actinic; Male; Membrane Proteins; Neck; Skin; Skin Neoplasms; Sunlight; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Successful treatment of proliferative verrucous leukoplakia with 5% topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Female; Humans; Imiquimod; Leukoplakia, Oral; Treatment Outcome | 2017 |
Squamous cell carcinoma of the penis successfully treated with imiquimod 5% cream in a porphyria cutanea tarda patient.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Porphyria Cutanea Tarda; Treatment Outcome | 2017 |
Pseudocarcinomatous Epithelial Hyperplasia Induced by Imiquimod: A Mimic of Cutaneous Squamous Cell Carcinoma.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Squamous Cell; Diagnosis, Differential; Facial Dermatoses; Female; Forehead; Humans; Hyperplasia; Imiquimod | 2017 |
Definitive surgical treatment of 24 skin cancers not cured by prior imiquimod therapy: a case series.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Mohs Surgery; Skin Neoplasms; Treatment Outcome | 2008 |
Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Hydroxyurea; Hyperpigmentation; Imiquimod; Male; Myeloproliferative Disorders; Nail Diseases; Skin Neoplasms | 2008 |
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells.
Topics: Aminoquinolines; Antigens, CD; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Movement; Down-Regulation; E-Selectin; Endothelial Cells; Forkhead Transcription Factors; Humans; Imiquimod; Immune System; Immunologic Memory; Interleukin-10; Interleukin-6; Lymphocyte Activation; Nitric Oxide Synthase Type II; Skin; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tumor Escape | 2008 |
Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient.
Topics: Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratosis, Actinic; Kidney Transplantation; Skin Neoplasms | 2008 |
Coexisting perianal squamous cell carcinoma, Bowen's disease, and condylomata acuminata treated with topical imiquimod 5%.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Anus Neoplasms; Bowen's Disease; Carcinoma, Squamous Cell; Condylomata Acuminata; Female; Humans; Imiquimod; Immunologic Factors; Middle Aged; Neoplasms, Multiple Primary; Skin Neoplasms | 2008 |
Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Imiquimod; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2008 |
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Biopsy; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Division; Granzymes; Humans; Imiquimod; In Vitro Techniques; Interferon-gamma; Interleukin-10; Lymphocyte Activation; Perforin; Pore Forming Cytotoxic Proteins; Signal Transduction; Skin Neoplasms; Transforming Growth Factor beta | 2009 |
A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Topics: Ambulatory Surgical Procedures; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cheek; Cost-Benefit Analysis; Curettage; Frozen Sections; Humans; Imiquimod; Mohs Surgery; Plastic Surgery Procedures; Skin Neoplasms | 2009 |
Bone invasion by squamous cell carcinoma in situ (Bowen's disease) of the finger during treatment with imiquimod 5% cream: case report.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Finger Joint; Fingers; Humans; Imiquimod; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Radiography; Skin Neoplasms | 2010 |
The use of imiquimod in the treatment of periocular tumours.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2010 |
Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Arsenic; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Neoplasm Recurrence, Local; Psoriasis; Skin Neoplasms | 2010 |
Current management of actinic keratoses.
Topics: Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms | 2010 |
Detection and treatment of preclinical actinic keratoses (PAK).
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis, Actinic; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Aging | 2010 |
The efficacy of imiquimod on dysplastic lesions of the oral mucosa: an experimental model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Squamous Cell; Imiquimod; Male; Mouth Mucosa; Mouth Neoplasms; Precancerous Conditions; Rats; Rats, Wistar | 2010 |
Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Topics: Algorithms; Aminoquinolines; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryosurgery; Curettage; Dermatology; Diagnosis, Differential; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Mohs Surgery; Photochemotherapy; Precancerous Conditions; Reproducibility of Results; Skin Neoplasms; Terminology as Topic; United States | 2010 |
Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
Topics: Acitretin; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms; Treatment Outcome | 2011 |
What's new in the treatment of actinic keratoses?
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diterpenes; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms | 2011 |
Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
Topics: Acitretin; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms | 2011 |
Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck.
Topics: Aminoquinolines; Analysis of Variance; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Imiquimod; Injections, Intraperitoneal; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Receptors, Opioid; Reference Values; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous; Treatment Outcome; Tumor Burden; Up-Regulation | 2012 |
Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cryotherapy; Female; Follow-Up Studies; Humans; Imiquimod; Immunotherapy; Male; Nitrogen; Retrospective Studies; Skin Neoplasms | 2011 |
Persistent erythematous lesion of the vulva: a diagnostic and treatment challenge.
Topics: Administration, Topical; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome; Vulva | 2012 |
Solar cheilosis: an ominous precursor part II. Therapeutic perspectives.
Topics: Administration, Topical; Aminoquinolines; Biopsy; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Diagnosis, Differential; Diclofenac; Female; Fluorouracil; Humans; Imiquimod; Lip Neoplasms; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms; Sunlight | 2012 |
Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Transformation, Neoplastic; Cytokines; Dendritic Cells; Epidermis; Imiquimod; Immunoenzyme Techniques; Keratinocytes; Mice; Mice, Transgenic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; STAT3 Transcription Factor; Th1 Cells; Th17 Cells; Ultraviolet Rays | 2013 |
Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
Topics: Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Humans; Imiquimod; Mouth Neoplasms; Necrosis; Toll-Like Receptor 7; Tumor Cells, Cultured | 2012 |
Human papillomavirus type 73 associated with multiple cutaneous squamous cell carcinomas in an immunosuppressed patient.
Topics: Adult; Aminoquinolines; Amputation, Surgical; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA, Viral; Fingers; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Lip Neoplasms; Male; Mohs Surgery; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin Neoplasms | 2012 |
Effects of imiquimod and low-intensity laser (λ660 nm) in chemically induced oral carcinomas in hamster buccal pouch mucosa.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cheek; Combined Modality Therapy; Cricetinae; Imiquimod; Low-Level Light Therapy; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms | 2013 |
[Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Cryotherapy; Female; Gammapapillomavirus; Humans; Imiquimod; Immunocompromised Host; Laser Therapy; Lasers, Gas; Male; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Risk; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Warts | 2012 |
Arbor cutis: hyperkeratotic plaque secondary to the use of imiquimod for the treatment of squamous cell carcinoma in situ.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Eruptions; Female; Forearm; Humans; Imiquimod; Keratosis; Skin Neoplasms | 2013 |
Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Interferon Inducers; Male; Penile Neoplasms | 2002 |
Catching skin cancer early. New treatments aim to keep keratoses from developing into invasive cancer.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms | 2002 |
Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimod.
Topics: Aminoquinolines; Carcinoma, Squamous Cell; Electrosurgery; Female; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Middle Aged; Mouth Neoplasms; Papilloma | 2003 |
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Pemphigus; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Diseases; Vulvar Neoplasms | 2003 |
New and emerging treatments for nonmelanomas and actinic keratoses.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diclofenac; Humans; Imiquimod; Keratosis; Photochemotherapy; Skin Neoplasms | 2003 |
Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cytochrome c Group; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Imiquimod; Immunologic Factors; In Situ Nick-End Labeling; Keratinocytes; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured; Up-Regulation | 2003 |
Treatment of Bowen's disease of the penis with imiquimod 5% cream.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Emollients; Humans; Imiquimod; Male; Middle Aged; Ointments; Penile Neoplasms; Treatment Outcome | 2003 |
Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome | 2003 |
Treatment of large facial Bowen's disease: case report.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Humans; Imiquimod; Ointments; Treatment Outcome | 2003 |
[Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy].
Topics: Adjuvants, Immunologic; Alleles; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cerebellar Neoplasms; Disease Models, Animal; Genes, Tumor Suppressor; Hedgehog Proteins; Humans; Imiquimod; Medulloblastoma; Membrane Proteins; Mice; Mutation; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface; Signal Transduction; Skin Neoplasms; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Veratrum Alkaloids | 2003 |
Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Skin Neoplasms | 2004 |
Successful treatment of invasive squamous cell carcinoma using topical imiquimod.
Topics: Administration, Topical; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Face; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Invasiveness; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2004 |
Invasive squamous cell carcinoma treated with imiquimod 5% cream.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Leg; Male; Neoplasm Invasiveness; Ointments; Skin Neoplasms; Treatment Outcome | 2004 |
Localized pemphigus foliaceus induced by topical imiquimod treatment.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Eruptions; Face; Facial Dermatoses; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms | 2004 |
Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cytokines; Female; Humans; Imiquimod; Immunohistochemistry; Leukocytes, Mononuclear; Macrophages; Male; Middle Aged; Skin Neoplasms | 2004 |
Infiltrative squamous cell carcinoma on the scalp after treatment with 5% imiquimod cream.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Squamous Cell; Dosage Forms; Head and Neck Neoplasms; Humans; Imiquimod; Male; Scalp; Skin Neoplasms | 2005 |
Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratinocytes; Male; Skin Neoplasms | 2005 |
Imiquimod 5% cream: a new treatment for Bowen's disease.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Biopsy; Bowen's Disease; Carcinoma, Squamous Cell; Epidermis; Female; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms; Time Factors; Treatment Outcome | 2005 |
Imiquimod and squamous cell cancer.
Topics: Aminoquinolines; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Precancerous Conditions; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2005 |
Imiquimod to treat basal cell and squamous cell carcinomas.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Approval; Humans; Imiquimod; Patient Selection; Skin Neoplasms; United States; United States Food and Drug Administration | 2005 |
Successful treatment of penile Bowen's disease with 5% imiquimod cream.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Penile Diseases; Skin Neoplasms; Treatment Outcome | 2005 |
Therapy of cutaneous squamous cell carcinoma in two retirement home residents.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Hand Dermatoses; Homes for the Aged; Humans; Imiquimod; Skin Neoplasms; Surgical Flaps; Treatment Outcome | 2005 |
Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Oral; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Counseling; Cyclosporine; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Ointments; Skin; Skin Neoplasms; Sunscreening Agents; Time Factors | 2005 |
Treatment of multiple lesions of Bowen's disease and squamous cell carcinoma with topical imiquimod.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2005 |
Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Neoplasm Invasiveness; Ointments; Skin Neoplasms; Treatment Outcome | 2006 |
Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometry.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Automation; Carcinoma, Squamous Cell; Cell Line; Cytological Techniques; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Keratinocytes; Toll-Like Receptors | 2006 |
A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Therapy, Combination; Epidermodysplasia Verruciformis; Humans; Imiquimod; Interferons; Male; Middle Aged; Scalp; Skin Neoplasms | 2006 |
Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Head and Neck Neoplasms; Humans; Imiquimod; Leg; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Scalp; Skin Neoplasms; Treatment Outcome | 2006 |
Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses.
Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratoacanthoma; Keratosis; Male; Middle Aged; Skin Neoplasms; Ultraviolet Rays | 2006 |
Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Cytokines; Drug Evaluation; Drug Synergism; Fingers; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Prodrugs; Remission Induction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2006 |
Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Epidermodysplasia Verruciformis; Humans; Imiquimod; Male; Membrane Proteins; Mutation; Skin Neoplasms | 2007 |
Treating actinic keratoses with imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Facial Dermatoses; Humans; Imiquimod; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms | 2007 |
Conservative management of recurrent nasal squamous papilloma with topical immunomodulators.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Squamous Cell; Humans; Imiquimod; Nose Neoplasms; Papilloma | 2007 |
Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2007 |
Squamous cell carcinoma on the scalp following treatment with 5% imiquimod cream.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Keratosis; Male; Radiodermatitis; Scalp; Skin Neoplasms | 2007 |
Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream.
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cat Diseases; Cats; Ear Auricle; Female; Imiquimod; Skin Neoplasms; Treatment Outcome | 2008 |
Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function.
Topics: Adenocarcinoma; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Head and Neck Neoplasms; Humans; Imiquimod; Immunity; Narcotic Antagonists; Pancreatic Neoplasms; Receptors, Opioid; RNA, Small Interfering; Up-Regulation | 2008 |
Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms | 2008 |
Bowen's disease of the penis treated with topical imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Ointments; Penile Neoplasms; Skin Neoplasms | 2008 |
Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; HIV Infections; HIV-1; Humans; Imiquimod; Male; Middle Aged | 2001 |
Topical imiquimod to treat intraepidermal carcinoma.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Nose; Photosensitivity Disorders; Precancerous Conditions; Skin Neoplasms; Thorax | 2001 |
Successful topical immunotherapy of bowenoid papulosis with imiquimod.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Interferon Inducers; Vulvar Neoplasms | 2001 |
Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Ointments; Penile Neoplasms; Skin Neoplasms | 2002 |